Top 5 Takeaways Oral Antivirals for COVID-19: The study analyzes the dispensing of oral antiviral drugs, Paxlovid and Lagevrio, for COVID-19 treatment, focusing on zip code-level social vulnerability in the

Top 5 Takeaways Pronounced Disparities: From April to July 2022, Paxlovid treatment among COVID-19 patients aged ≥20 years was significantly lower for Black (35.8% less) and Hispanic (29.9% less) patients

Top 5 Takeaways Paxlovid, an outpatient antiviral medication, is linked to a 51% reduction in hospitalization rates for COVID-19 among U.S. adults when prescribed within 5 days of diagnosis. This